In the latest trading session, Boston Scientific (BSX) closed at $102.27, marking a +0.32% move from the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.46%. On the ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price ...

Boston Scientific Corp. closed 0.01% short of its 52-week high of $101.65, which the company reached on January 22nd.

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...

At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.

Boston Scientific’s BSX robust expansion of operations ... The renowned manufacturer of medical devices and products has a market capitalization of $131.64 billion. BSX beat on earnings in ...

Beyond technological innovations and effectiveness, a key factor is its cost-reduction approach to its products, enabling greater adoption by the medical community. Boston Scientific has performed ...